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OBJECTIVES: To operationalize and compare three mod-
els of frailty, each representing a distinct theoretical view of
frailty: as deficiencies in function (Functional Domains
model), as an index of health burden (Burden model), and
as a biological syndrome (Biologic Syndrome model).
DESIGN: Cross-sectional analysis.
SETTING: 2004 wave of the Health and Retirement Study, a
nationally representative, longitudinal health interview survey.
PARTICIPANTS: Adults aged 65 and older (N 5 11,113)
living in the community and in nursing homes in the United
States.
MEASUREMENTS: The outcome measure was the pres-
ence of frailty, as defined according to each frailty model.
Covariates included chronic diseases and sociodemograph-
ic characteristics.
RESULTS: Almost one-third (30.2%) of respondents were
frail according to at least one model; 3.1% were frail ac-
cording to all three models. The Functional Domains model
showed the least overlap with the other models. In contrast,
76.1% of those classified as frail according to the Biologic
Syndrome model and 72.1% of those according to the Bur-
den model were also frail according to at least one other
model. Older adults identified as frail according to the
different models differed in sociodemographic and chronic
disease characteristics. For example, the Biologic Syndrome
model demonstrated substantial associations with older age
(adjusted odds ratio (OR) 5 10.6, 95% confidence interval
(CI) 5 6.1–18.5), female sex (OR 5 1.7, 95% CI 5 1.2–2.5),
and African-American ethnicity (OR 5 2.1, % CI 5 1.0–4.4).
CONCLUSION: Different models of frailty, based on
different theoretical constructs, capture different groups of
older adults. The different models may represent different
frailty pathways or trajectories to adverse outcomes such as
disability and death. J Am Geriatr Soc 57:830–839, 2009.
Key words: frailty; disability; chronic disease
Frailty has been an imprecise and variously defined termused to indicate that heterogeneous group of older
adults who undergo decline and are especially vulnerable.1–4
Models have arisen to define and operationalize frailty in a
more specific and standardized manner. These models de-
rive from distinctive theoretical views of how frailty devel-
ops and manifests itself in older adults. Research comparing
the models is limited, yet how frailty is understood and
modeled affects aging research, for example, where frailty
fits into the constructs of morbidity, disability, and death
and how frailty can improve understanding of prognosis
and the effect of illness on patients and families. From a
clinical standpoint, how frailty is understood affects efforts
to compress morbidity, enhance function, and delay death.
The present study investigated three models, each rep-
resenting a distinctive perspective of frailty. It compared the
models and the older adults that the models identify as frail.
Several related models were not included in this study be-
cause they are more focused in scope (e.g., sarcopenia,5
failure to thrive6) or are research models with less direct
applicability to clinical settings and population-based re-
search (e.g., allostatic load, which includes multiple serum
and urine biomarker measures7).
Strawbridge and colleagues conceived of frailty as ‘‘a
grouping of problems and losses of capability which make
the individual more vulnerable to environmental challenge’’
and proposed an early frailty model based on deficiencies in
four domains of functioning (physical, nutritive, cognitive,
and sensory) (Table 1).8 They developed this Functional
Domains model of frailty in the Alameda County Study
(ACS).8 The model was the first to combine deficits across
these domains into a single measure.
Rockwood and colleagues developed a frailty index
(FI) as a measure of deficit accumulation, that is, a measure
of the cumulative burden of, for example, symptoms, dis-
eases, conditions, and disability (Table 2).9 They developed
this Burden model of frailty in the Canadian Study of
Health and Aging.10,11 In contrast to the Functional Do-
mains model, the items that comprise the FI include but are
not limited to conditions that are geriatric in nature.
Fried and colleagues postulated frailty to be a ‘‘biologic
syndrome of decreased reserve and resistance to stressors,
resulting from cumulative declines across multiple
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physiologic systems,’’ and defined a frailty phenotype in
terms of five components present in a hypothesized cycle of
frailty (Table 3).12,13 Two components are defined in terms
of physical performance measures. They developed this Bi-
ologic Syndrome model of frailty in the Cardiovascular
Health Study (CHS).14 The model was later replicated in
the Women’s Health and Aging Studies (WHAS) in women
aged 70 to 79.15
The goal of the current research was to operationalize
and compare the three frailty models in a nationally rep-
resentative population sample, the 2004 wave of the Health
and Retirement Study (HRS). The models were analyzed
in two steps. First, each model was operationalized in the
HRS population and compared with the original model in
the original study population. Second, the three models
were compared with each other. It was hypothesized that
the frailty models, having different theoretical foundations,
would differ in identifying older adults as frail. It was fur-
ther hypothesized that sociodemographic and clinical
differences would exist between the populations identified
as frail according to the three models.
METHODS
Data
The data used in this study were from the 2004 wave of the
HRS, a population-based longitudinal health interview sur-
vey of a cohort of adults aged 51 and older in the United
States.16,17 Sponsored by the National Institute on Aging
and performed by the Institute for Social Research at the
University of Michigan, the HRS is designed to study health
transitions in older adults. The HRS conducts interviews
with respondents and their spouses. Respondents include
adults living in the community and those residing in long-
stay nursing facilities.
The Health Sciences Institutional Review Board at the
University of Michigan approved the HRS. The data used
for this analysis are publicly available and contain no
unique identifiers, thus ensuring respondent anonymity.
Study Population
Of the 20,129 respondents interviewed in the 2004 wave
core survey, 11,113 were aged 65 and older (Figure 1).
When the eligible respondent was unable to be interviewed,
often because of medical or cognitive problems, a proxy
(n 5 1,226), frequently the spouse (n 5 649), was enlisted to
answer questions for that respondent. The 2004 wave in-
cluded physical performance measures on a subsample of
community-dwelling nonproxied respondents (n 5 3,274);
of these, 2,111 were aged 65 and older.
Variables and Their Measurement
Frailty
Data from the core survey and from the physical perfor-
mance measures subsample (for the Biologic Syndrome
model) were used to operationalize the three frailty models
in the HRS (Tables 1, 2, and 3).
Functional Domains Model. The original model in the
ACS consisted of 16 self-report items grouped into four
domains of functioning.8 Subjects were classified as frail if
they had difficulties in two or more domains. The physical
functioning domain in the ACS included dizziness, loss of
balance, weakness in the arms, and weakness in the legs.
Physical functioning was defined in the HRS as dizziness as
a persistent problem, two or more falls in the previous 2
years, or difficulty lifting 10 pounds. The nutritive func-
tioning domain in the ACS included loss of appetite and
unexplained weight loss. Nutritive functioning was defined
in the HRS as 10% or greater weight loss in the previous 2
years (derived from comparison of self-reported weight in
2004 and 2002) or a body mass index (BMI) less than
18.5 kg/m2 (derived from self-reported height and weight).
The cognitive functioning domain in the ACS included










Physical functioning Often or very often had difficulty with
dizziness, loss of balance, weakness in
arms, or weakness in legs
17 Dizziness as persistent problem, 2 falls
in previous 2 years, or difficulty lifting 10
pounds
42
Nutritive functioning Often or very often had difficulty with loss
of appetite or unexplained weight loss
5 Weight in wave 2002 minus weight in
wave 2004 10% of weight in wave
2002 or body mass index o18.5 kg/m2
9
Cognitive functioning Often or very often had difficulty with
memory or attention
26 Mild to severe cognitive impairment on
performance-based measure or according
to proxy and interviewer rating
9
Sensory problems Some or great difficulty with any of six
vision and hearing tasks (e.g., reading
newspaper, hearing normal conversation)
46 Fair or poor eyesight despite use of
corrective lenses or fair or poor hearing
despite use of hearing aides
41
Frail Status (2 domains
with deficiencies)
26 29
Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the
sample and differential nonresponse.
Adults aged 65.
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memory and attention difficulties. Cognitive functioning
was defined in the HRS using a performance-based measure
to assess the degree of cognitive impairment (see below).
The sensory functioning domain in the ACS included vision
and hearing difficulties in different situations. Sensory func-
tioning was defined in the HRS as fair or poor vision or
hearing despite the use of corrective lenses or hearing aides.
Burden Model. The FI in the CHAS comprised 70
measures that may be generally categorized as diseases,
neurological conditions, or impairments in cognition,
mood, mobility, or function.9 Thirty-eight of the measures
were able to be replicated in the HRS, including at least
60% of the measures in each general category (except neu-
rological conditions), thus achieving a broad representation
of the accumulated deficits that the FI was intended to sig-
nify. (The individual measures for each respondent were
mapped to an interval scale (from 0 to 1) to produce
the composite FI, scaled from 0 to 1, for that respondent.)
The FI, as originally developed, conceptualizes frailty as a
continuum, but researchers have used FI values of 0.2 and
of 0.25 as cutpoints to distinguish frail from not frail.9 The
current study used a FI of 0.2 or above to classify respon-
dents as frail. (Analyses were also performed with a FI of
0.25 or above (data not shown).)
Biologic Syndrome Model. The original model was
specified using five frailty criteria.13 Subjects were classified
as frail if they met three or more criteria. Weight loss was
defined in the CHS as the self-reported unintentional loss of
10 or more pounds in the previous year. Weight loss was
defined in the HRS as 10% or greater weight loss in the
previous 2 years or a BMI less than 18.5 kg/m2. The same
Center for Epidemiologic Studies Depression Scale (CES-
D)18 measures used in the CHS to define exhaustion were
also used in the HRS; respondents answered yes or no to
whether they had experienced either CES-D item for much
of the time during the previous week. Low activity was
defined in the CHS in terms of kilocalories expended per
week, based on responses to selected items from the Min-
nesota Leisure Time Activity questionnaire.15,19,20 Three
questions in the HRS asked respondents about their fre-
quency of mild, moderate, and vigorous physical activities.
An activity scale weighted according to the intensity and the
frequency of these activities was constructed.21 Low activ-
ity was defined in the HRS as the lowest 20% for each sex.
Slowness was defined in the HRS in terms of usual-pace
walking speed measured over 8 feet (vs 15 feet in the CHS),
using the same cutpoints as in the CHS (after adjusting for
distance). Weakness was defined in the HRS by assessing
grip strength, using the same cutpoints as in the CHS. Re-
spondents unable to complete the respective physical per-
formance tests were included as slow and as weak.
Chronic Diseases
The following chronic diseases were included in the ana-
lyses: hypertension, heart disease, chronic lung disease, di-
abetes mellitus, cancer, musculoskeletal conditions, and
psychiatric problems. Each disease was limited to its active
or severe form (e.g., receiving treatment for the dis-
ease).22,23
Stroke and depression were exclusion criteria for some
analyses (see below for further explanation). Respondents
with stroke were defined as those reporting stroke who re-
quired medication for the stroke (or its complications) or
who had remaining problems from the stroke. Respondents
2004 wave
(includes respondents living in community and in long-stay nursing facilities;
includes respondents with proxies)
n=20,129 (83.6 million)*
≥65 years old: n=11,113 (37.1 million),* replicates ACS
≥70 years old: n=7,719 (27.0 million),* replicates CSHA
Subsample of respondents completing
physical performance measures
(excludes respondents with proxies
and/or in long-stay nursing facilities)
n=3,274 (82.7 million)†
≥65 years old: n=2,111 (35.5 million)†
replicates CHS (“less restricted” version)
Respondents ≥65 years old who
completed performance measures
(excludes those with stroke, depression,
or moderate/severe cognitive impairment)
n=1,657 (28.2 million)†
replicates CHS (“restricted” version)
Figure 1. Diagram depicting Health and Retirement Study (HRS) 2004 wave population sample and physical performance measures
population subsample. Weighted percentages were derived using HRS respondent population weights to adjust for differential probability
of selection into the sample and differential nonresponse. National population estimates after weighting, using respondent weights for
entire 2004 wave sample. wNational population estimates after weighting, using respondent weights for 2004 wave physical performance
measures sub-sample. ACS 5 Alameda County Study; CSHA 5 Canadian Study of Health and Aging; CHS 5 Cardiovascular Health Study.
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with depression were defined as those with a positive re-
sponse to four (of eight) CES-D items.
Cognitive Impairment
Cognitive impairment (mild to severe) is a component in the
Functional Domains model and in the Burden model. (In
addition to stroke and depression, moderate to severe cog-
nitive impairment was a third exclusion criterion for some
analyses.) Cognitive status was assessed using a perfor-
mance-based measure, a modified version of the Telephone
Interview for Cognitive Status (TICS), a validated cog-
nitive screening instrument patterned on the Mini-Mental
State Examination24 and specifically designed for popula-
tion-based studies.25–27 Moderate to severe impairment
was defined as a score of 7 or less on the 35-point cogni-
tive scale and mild impairment as a score of 8 to 10. For
respondents unable to complete the interview, a proxy
respondent was asked to assess the respondent’s memory.
The presence and degree of cognitive impairment for these
respondents were determined by combining the proxy’s as-
sessment of the respondent’s memory with the interviewer’s
assessment of the respondent’s cognitive function.27
Sociodemographic Characteristics
Sociodemographic variables included age, sex, race (Cau-
casian, African American, Hispanic), marital status, edu-
cational attainment, net worth (total household assets
minus current debt),16 and living arrangement (lives with
others, alone, or in a long-stay nursing facility).
Statistical Analysis
To adjust for the complex sample design of the HRS, the
differential probability of selection, and nonresponse, all
analyses were weighted and adjusted using the statistical
package Stata (Release 9.0, StataCorp., College Station,
TX). The 2004 wave sample and the physical performance
measures subsample (Figure 1) had different sets of respon-
dent weights, each set specific to each sample. As a result,
for both the 2004 wave sample and the subsample, the
study was able to take advantage of the nationally repre-
sentative data to produce national population estimates.
The first set of analyses (Tables 1, 2, and 3) estimated
the prevalence of frailty for each frailty model, as defined in
the HRS, and compared it with that of the original model,
as developed in the original study population. For each
frailty model, the HRS population sample was selected so as
to replicate, as closely as possible, each original study pop-
ulation and its eligibility criteria (Figure 1). To replicate the
ACS,28 the Functional Domains model was developed in
the HRS 2004 wave sample of adults aged 65 and older. The
sample consisted of 11,113 respondents, representing 37.1
million adults aged 65 and older in the United States in
2004. To replicate the CHAS,10,11 the Burden model was
developed in the HRS 2004 wave sample of adults aged 70
and older. The sample consisted of 7,719 respondents, rep-
resenting 27.0 million adults aged 70 and older nationally.
To replicate the CHS,14 the Biologic Syndrome model was
developed in the sample of HRS respondents aged 65 and
older who completed the performance measures and did not
have stroke, depression, or moderate to severe cognitive
impairment (single diseases or conditions that could by
themselves result in frailty characteristics).13 The resulting
sample consisted of 1,657 respondents, representing 28.2
million adults aged 65 and older nationally.
The second set of analyses (Figure 2, Tables 4 and 5)
compares the three frailty models with one another in the
same HRS population sample. For this comparison, the
more ‘‘restricted’’ population sample (the sample that rep-
licated the CHS) was chosen: respondents were aged 65 and
older; completed the performance measures; and did not
have stroke, depression, or moderate to severe cognitive
impairment (n 5 1,657).
The third set of analyses (data not shown) also com-
pares the three frailty models with one another in the same
population sample, the sample of HRS respondents aged 65
and older who completed the performance measures
(n 5 2,111). For this ‘‘less restricted’’ sample, the exclusion
criteria of stroke, depression, and moderate to severe cog-
nitive impairment were omitted.
Standard descriptive methods were used to estimate
prevalences, determine confidence intervals, and make com-
parisons between frail groups. Logistic regression models
were used to examine the multivariate association between
frailty and sociodemographic characteristic and chronic
disease covariates. The dependent variable in these models
was frailty, as defined according to each frailty model.
RESULTS
The first set of analyses (Tables 1, 2, and 3) compared each
frailty model, as developed in the HRS, with the original
model, as developed in the original study population. For
example, the Biologic Syndrome model in the HRS was
compared with the Biologic Syndrome model in the CHS.
For each model, the prevalence of frailty and of each frailty
criterion in the HRS population was compared with that in
the original study populations. In general, prevalences of
frailty in the HRS were consistent with those in the original
study populations: for example, Functional Domains
model, HRS 29%, ACS 26%, and Biologic Syndrome
model, HRS 11%, CHS 7%. The greatest discrepancies


















Figure 2. Venn diagram depicting how the models differ in
identifying respondents as frail. Weighted percentages were de-
rived using Health and Retirement Study respondent population
weights to adjust for differential probability of selection into the
sample and differential nonresponse.
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The prevalence of frailty and of each frailty criterion
for the Biologic Syndrome model in the HRS was also
compared with that in the CHS and in the WHAS for the
subgroup of women aged 70 to 79 (n 5 367, data not
shown). The prevalence of frailty for women in this age
group in the HRS (10.5%) was consistent with that for the
CHS (7.3%) and the WHAS (12.7%).
The next set of analyses (Figure 2, Tables 4 and 5)
compared the three frailty models with one another in the
same population sample, the ‘‘restricted’’ HRS subsample
of 1,657 respondents. The frailty models differed substan-
tially in how they classified respondents as frail. The Venn
diagram in Figure 2 illustrates how the populations
identified as frail according to each model overlapped.
Overall, 30.2% of respondents were frail according to
at least one model and 3.1% according to all three
models. The Functional Domains model showed the least
overlap with the other models. In contrast, 76.1% of those
classified as frail according to the Biologic Syndrome
model and 72.1% of those according to the Burden model
were also frail according to at least one other model
(Table 4).
Table 4 shows the weighted distributions for key de-
mographic, socioeconomic, and health covariates for the
study population (n 5 1,657) (column 1) and for the re-
spondents classified as frail according to each frailty model
(columns 2–4). Respondents classified as frail generally
were older; were more likely to be female, from a minority
ethnic group, and unmarried; had less education and a
lower net worth; and were more likely to live alone than
those not identified as frail. However, notable differences
were found between the models. For example, frailty ac-
cording to the Biologic Syndrome model had substantially
greater prevalence in the oldest-old, women, and African
Americans. These findings were present but less marked in
the Functional Domains and Burden groups.













Cumulative burden scale comprising diseases,
neurological conditions, and impairments in cognition,
mood, mobility, and function measures
70-item scale; Frailty
Index 0.25
Not available 38-item scale; Frailty
Index 0.2
32
Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the
sample and differential nonresponse.
Adults aged 70.
Table 3. Measures Used to Operationalize Biologic Syndrome Model: Frailty as a Biologic Syndrome/Phenotype
Frailty-Defining
Criterion






Weight loss Lost 410 pounds unintentionally in last year 6 Weight in wave 2002 minus weight in wave 2004
10% of weight in wave 2002 or BMI o18.5 kg/m2
7
Exhaustion Yes to either of two CES-D items:
(i) Felt that everything I did was an effort in last week.
(ii) Could not get going in last week.
17 Yes to either of two CES-D items:
(i) Felt that everything I did was an effort in last week.




Kilocalories of physical expenditure per week, based
on 18-item activity scale,z lowest quintile (stratified
according to sex)
22 Frequency of three intensities of activity, lowest
quintile (stratified according to sex)
20
Slowness Time to walk 15 ft: Slowest 20% (stratified according
to sex and height)
20 Time to walk 8 ft, converted to time to walk 15 ft. Cutoff
criteria according to sex and height remain the same
30
Weakness Grip strength: Weakest 20% (stratified according to
sex and BMI)







Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the
sample and differential nonresponse.
Adults aged 65 who completed physical performance measures, excluding those with Parkinson’s disease; stroke; Mini-Mental State Examination scores
o18; or taking carbidopa-levodopa, donepezil hydrochloride, or antidepressants.
wAdults aged 65 who completed physical performance measures, excluding those with stroke, moderate to severe cognitive impairment, or depression (4 out
of 8 Center for Epidemiologic Studies Depression Scale (CES-D) items).
zMinnesota Leisure Time Activity questionnaire.
BMI 5 body mass index.
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Table 4. Characteristics of the Study Population, Overall and According to Frailty Model
Characteristic
Weighted Percentage
Sample Population (N 5 1,657)
Frailty Models
Functional Domains (n 5 353) Burden (n 5 245) Biologic Syndrome (n 5 220)
Age
65–69 31.9 22.5 21.7 10.1
70–74 24.0 19.2 23.0 13.1
75–79 17.1 17.0 15.4 12.6
80 27.0 41.4 39.9 64.2
P-value o.001 o.001 o.001
Sex
Male 44.5 36.3 32.3 28.5
Female 55.5 63.7 67.7 71.5
P-value .004 .002 o.001
Race
Caucasian 88.1 83.5 85.9 78.2
African American 7.4 11.8 10.1 16.7
Hispanic 4.5 4.7 3.9 5.1
P-value .003 .35 o.001
Marital status
Married 64.4 54.5 52.8 43.3
Unmarried 35.6 45.5 47.2 56.7
P-value .002 .003 o.001
Years of education
o12 22.2 28.4 32.6 35.1
12 36.7 38.1 34.9 35.3
412 41.1 33.5 32.6 29.6
P-value .007 .003 o.001
Net worth, $
40,000 16.3 22.0 27.6 32.9
40,001–155,000 21.5 31.3 30.1 26.3
155,001–420,000 27.3 21.7 20.7 21.9
4420,000 34.8 25.1 21.6 18.9
P-value o.001 o.001 o.001
Living arrangement
With others 73.6 68.6 69.3 64.5
Alone 26.4 31.4 30.7 35.5
P-value .03 .21 .02
Chronic diseases
Hypertension 53.6 59.5 74.1 64.6
P-value .12 o.001 .01
Heart disease 23.3 37.1 49.6 29.9
P-value o.001 o.001 .03
Lung disease 4.9 9.1 12.9 12.2
P-value .002 o.001 o.001
Diabetes mellitus 15.7 23.3 29.2 26.8
P-value o.001 o.001 .001
Cancer 3.3 3.9 7.3 4.7
P-value .57 .003 .38
Musculoskeletal 30.2 39.8 51.7 48.9
P-value .001 o.001 o.001
Psychiatric 4.0 4.1 9.2 5.6
P-value .94 o.001 .28
Number of chronic diseases
(Continued )
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Table 4 likewise shows the prevalence of chronic dis-
eases, cognitive impairment, and activity of daily living
(ADL) and instrumental activity of daily living (IADL) de-
pendency in the study population and in each frail popu-
lation. For each model, frail respondents had greater
prevalence of heart disease, lung disease, diabetes mellitus,
and musculoskeletal disorders. Frail respondents also had
greater prevalences of chronic diseases and of ADL and
IADL dependencies, which was in general most noted for
the Burden model.
Table 5 shows the association between frailty (for each
frailty model) and sociodemographic characteristics and
chronic diseases using multivariate logistic regression mod-
els. The Functional Domains and Biologic Syndrome models
were investigated in two steps, first including only sociode-
mographic variables in the respective models (Model 1 and
Model 4) and then introducing chronic disease variables
(Model 2 and Model 5). In the Biologic Syndrome model,
older age, female sex, African-American ethnicity, lower net
worth, lung disease, diabetes mellitus, and musculoskeletal
conditions were associated with frailty. These associations
generally were also found for the Functional Domains
model, although with smaller odds ratios. Chronic disease
variables make up the Burden model in part; hence, only the
association between frailty and demographic characteristics
was examined (Model 3). Significant associations were
found for older age, female sex, and net worth. For each of
the three frailty models, interactions between the indepen-
dent variables were systematically tested for, but none that
seemed meaningful were found.
Finally, the analyses in Figure 2 and Tables 4 and 5 were
repeated on the ‘‘less restricted’’ population sample (includ-
ing respondents with stroke, depression, and dementia,
n 5 2,111, data not shown). As expected, there was sub-
stantially greater prevalence of frailty for each model:
Functional Domains, 26.1%, Burden, 24.7%, and Biologic
Syndrome, 15.9%. Nearly 40% of respondents were frail
according to at least one model, and 7.0% were frail ac-
cording to all three models. The association between frailty
and African-American ethnicity was smaller than in the
analyses that excluded these three diseases or conditions. As
expected, the association between frailty and heart disease
and psychiatric illness increased. The prevalence of mild to
severe cognitive impairment for the models was 12.0%





Sample Population (N 5 1,657)
Frailty Models
Functional Domains (n 5 353) Burden (n 5 245) Biologic Syndrome (n 5 220)
1 76.7 87.4 96.8 90.9
P-value o.001 o.001 o.001
2 41.7 61.8 83.8 69.0
P-value o.001 o.001 o.001
3 13.9 22.1 39.2 25.4
P-value o.001 o.001 o.001
Cognitive impairment
Mild 1.8 7.0 5.9 4.1
P-value o.001 o.001 .16
Number of activity of daily living dependencies
1 4.8 15.3 25.6 20.5
P-value o.001 o.001 o.001
2 1.7 4.8 10.6 8.3
P-value .001 o.001 o.001
3 0.6 1.5 3.7 2.5
P-value .05 o.001 .008
Number of instrumental activity of daily living dependencies
1 7.4 20.0 31.4 24.2
P-value o.001 o.001 o.001
2 2.2 8.0 11.2 8.7
P-value o.001 o.001 o.001
3 0.5 2.4 2.8 3.5
P-value o.001 o.001 o.001
Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the
sample and differential nonresponse.
Proportions are related to the columns and not the rows; the columns for each variable (not the rows) add to 100%. For example, of respondents with frailty
(Biologic Syndrome model), 28.5% were male and 71.5% female.
P-value from the ch-square test for association between the indicated variable and frailty.
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DISCUSSION
This study examined three models of frailty, each derived
from a different theoretical view of how frailty develops
and manifests itself in older adults. The goal of the research
was to operationalize each model in a population-based
sample using performance measures and to compare the
older adults identified as frail according to each model. To
the authors’ knowledge, this is the first study to do so using
nationally representative data including older men and
women across the age spectrum. Confirming the study’s
hypotheses, the models differed substantially in identifying
older adults as frail, and the individuals identified as frail
according to the models differed in their sociodemographic
and chronic disease characteristics. Thus, different models
of frailty, based on different theoretical constructs, captured
different groups of older adults.
The extent to which individual measures in the models
can be replicated limits attempts to operationalize and
compare models of frailty in population-based data sets.
The Functional Domains model,8 although older and com-
prising common domains of functioning, has not been de-
veloped in other large datasets. The Burden model9 has
been developed in the National Long-Term Care Survey
and in a number of international data sets.29,30 Its 70 com-
posite measures may limit its replication, although its de-
velopers have demonstrated that the model does not depend
on any specific measures or on any specific number
of measures.9 The Biologic Syndrome model13 has been
widely developed, including in the WHAS,15 the Women’s
Health Initiative Observational Study,31 and the Study of
Osteoporotic Fractures (women only),32,33 the Osteoporo-
tic Fractures in Men Study (men only),34 and CHAS (men
and women).9 Its use of physical performance measures
limits its replication; different studies have been able to
replicate the performance measures to varying extents,
sometimes by substituting self-report measures. The extent
to which population samples replicate the eligibility and
exclusion criteria of the study populations in which the
models were originally developed further limits comparison
of frailty models.
How frailty is conceptualized and defined has implica-
tions for research investigating its place in the disablement
process in older adults.35 Frailty is theorized to be related to
but distinct from disability, and validity is claimed in part
for each of the three models investigated here because of its
longitudinal association with disability. Frailty has also
Table 5. Odds Ratios for Association of Sociodemographic Characteristics and Chronic Diseases with Frailty
(N 5 1,657)
Characteristic




Model 1 Model 2w Model 3 Model 4 Model 5w
Age
70–74 1.1 (0.6–2.0) 1.0 (0.5–1.8) 1.3 (0.8–2.3) 1.8 (0.7–4.3) 1.6 (0.6–4.0)
75–79 1.5 (0.9–2.6) 1.4 (1.7–2.5) 1.3 (0.7–2.6) 2.6 (1.1–6.2) 2.4 (1.0–5.5)
80 2.6 (1.6–4.2) 2.2 (1.4–3.7) 2.2 (1.4–3.4) 10.2 (5.5–18.8) 10.6 (6.1–18.5)
Female 1.4 (1.0–1.9) 1.5 (1.0–2.2) 1.7 (1.1–2.5) 1.9 (1.3–2.7) 1.7 (1.2–2.5)
Race
African American 1.7 (1.0–2.6) 1.7 (1.1–2.7) 0.5 (0.2–1.2) 2.4 (1.1–5.0) 2.1 (1.0–4.4)
Hispanic 1.0 (0.5–1.7) 1.1 (0.6–2.2) 0.9 (0.5–1.8) 1.0 (0.4–2.1) 1.0 (0.4–2.2)
Married 1.1 (0.8–1.5) 1.0 (0.7–1.5) 1.1 (0.8–1.6) 1.3 (0.8–2.1) 1.3 (0.8–2.1)
Years of education
12 0.9 (0.6–1.4) 1.0 (0.7–1.4) 0.6 (0.4–1.0) 0.8 (0.5–1.4) 0.9 (0.5–1.5)
412 0.8 (0.5–1.1) 0.8 (0.5–1.2) 0.7 (0.4–1.1) 0.7 (0.4–1.2) 0.8 (0.4–1.3)
Net worth, $
40,001–155,000 1.3 (0.8–2.0) 1.5 (1.0–2.3) 0.8 (0.5–1.3) 0.6 (0.4–0.9) 0.7 (0.4–1.1)
155,001–420,000 0.6 (0.4–1.0) 0.8 (0.5–1.1) 0.4 (0.2–0.7) 0.4 (0.2–0.7) 0.5 (0.3–0.9)
4420,000 0.6 (0.4–1.0) 0.8 (0.5–1.3) 0.3 (0.2–0.6) 0.3 (0.2–0.5) 0.4 (0.2–0.7)
Chronic diseases
Hypertension 1.0 (0.7–1.5) 1.2 (0.9–1.8)
Heart disease 2.4 (1.7–3.4) 1.3 (0.8–2.0)
Lung disease 2.4 (1.2–4.5) 3.1 (1.5–6.4)
Diabetes mellitus 1.7 (1.2–2.4) 2.2 (1.2–3.7)
Cancer 1.1 (0.5–2.4) 1.6 (0.5–4.8)
Musculoskeletal 1.6 (1.1–2.3) 2.2 (1.4–3.4)
Psychiatric 1.0 (0.5–2.3) 1.9 (0.8–4.6)
Weighted percentages were derived using Health and Retirement Study respondent population weights to adjust for differential probability of selection into the
sample and differential nonresponse.
Adjusted for six demographic characteristics.
wAdjusted for six demographic characteristics and seven chronic diseases.
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been referred to as a geriatric syndrome or condition and
has been theorized to underlie other geriatric syndromes,
thus constituting a common risk factor for the other syn-
dromes.36 Yet the exact place of frailty in the disablement
pathway and in the pathophysiology of geriatric syndromes
in older adults is not clear. Conditions related to frailty (e.g.,
sarcopenia5 and allostatic load7) are similarly being inves-
tigated for their roles in older adult disability.
The current study suggests that different models of
frailty capture different but overlapping groups of older
adults, with estimates for the prevalence of frailty nation-
ally in community-dwelling older adults ranging from ap-
proximately 6 million for the Biologic Syndrome model to 9
million for the Functional Domains and Burden models.
Furthermore, the models classify as frail older adults with
different sociodemographic and chronic disease profiles.
For example, the current study’s findings replicated those of
other researchers showing a greater prevalence of frailty, as
defined according to the Biologic Syndrome model, in the
oldest old, women, and African Americans.37 These socio-
demographic associations were less pronounced for the
Functional Domains and Burden models.
One challenge for frailty research is to ascertain the
extent to which frailty can be a clinically useful concept,
that is, assisting with prognosis.35 For instance, there are
ongoing efforts to identify frail patients clinically, with the
aim of interrupting the frailty process leading to disability
and death. Also, identification of patients as frail may better
stratify them as appropriate or inappropriate for certain
interventions, such as surgical procedures or aggressive
chemotherapy. Although none of the frailty models is cur-
rently feasible for widespread clinical application, research
models will influence any consensus on a clinical definition
of frailty. One early frailty screening tool includes many of
the items making up the three models investigated in this
study.38 In comparison, as part of the Assessing Care of the
Vulnerable Elders initiative, the Vulnerable Elders Survey
provides a clinical measure of vulnerability with the goal of
identifying older adults at risk for functional decline or
death.39 Other researchers have taken a further step and
developed a prognostic index for mortality specifically for
the frail older adult population.40
This study has several limitations. First, the HRS is
based on self-report data (other than the physical perfor-
mance and cognitive measures). Most of the individual
measures that define each frailty model derive from self-
report data and are limited by the questions included in the
HRS survey, so exact replication of each frailty model is not
possible. The questions included in the HRS similarly limit
the chronic disease covariates; for example, the survey does
not have data on Parkinson’s disease. Finally, this study is
cross-sectional; further research is needed to examine frailty
longitudinally.
The chief strength of this research is that it is based on a
large, nationally representative surveyFthe HRSFthat
includes physical performance measures and a perfor-
mance-based determination of cognitive ability, in addition
to data on sociodemographic characteristics and chronic
diseases. Thus, these data enable the operationalization and
comparison of different models of frailty in the same pop-
ulation sample. Furthermore, the HRS samples across the
age range of older adults, including the oldest old. Finally,
the HRS is a biennial longitudinal survey that includes uti-
lization, disability, and mortality data, making possible
future studies that examine the cross-sectional and longi-
tudinal association of frailty with these outcomes.
Frailty models derived from different theoretical con-
structs identify different groups of older adults at risk for
disability and other adverse outcomes. Future research is
needed to compare the longitudinal outcomes of frailty for
the different models. The outcomes of frailty may vary for
the different models, or the models may identify different
paths or trajectories to the same adverse outcomes. Rather
than choosing a single model of frailty, different models
with different theoretical constructs may point to different
interventions to interrupt the processes resulting in frailty,
with the aims of enhancing function, minimizing disability,
and delaying death.
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